These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

354 related items for PubMed ID: 8340068

  • 1. Effects of ritanserin, a selective and specific S2-serotonergic antagonist, on portal pressure and splanchnic hemodynamics in rats with long-term bile duct ligation.
    Fernández M, Pizcueta P, García-Pagán JC, Feu F, Cirera I, Bosch J, Rodés J.
    Hepatology; 1993 Aug; 18(2):389-93. PubMed ID: 8340068
    [Abstract] [Full Text] [Related]

  • 2. Effects of ritanserin, a selective and specific S2-serotonergic antagonist, on portal pressure and splanchnic hemodynamics in portal hypertensive rats.
    Nevens F, Pizcueta MP, Fernández M, Bosch J, Rodés J.
    Hepatology; 1991 Dec; 14(6):1174-8. PubMed ID: 1959867
    [Abstract] [Full Text] [Related]

  • 3. N omega-nitro-L-arginine administration corrects peripheral vasodilation and systemic capillary hypotension and ameliorates plasma volume expansion and sodium retention in portal hypertensive rats.
    Lee FY, Colombato LA, Albillos A, Groszmann RJ.
    Hepatology; 1993 Jan; 17(1):84-90. PubMed ID: 8423045
    [Abstract] [Full Text] [Related]

  • 4. [Hyperdynamic status in a partial portal vein ligated (PVL) rat's portal hypertension model].
    Wang CT, Kuang YL, Chen ZP.
    Zhonghua Wai Ke Za Zhi; 1994 Sep; 32(9):573-5. PubMed ID: 7720436
    [Abstract] [Full Text] [Related]

  • 5. Splanchnic hyposensitivity to glypressin in a hemorrhage-transfused common bile duct-ligated rat model of portal hypertension: role of nitric oxide and bradykinin.
    Chen CT, Chu CJ, Lee FY, Chang FY, Wang SS, Lin HC, Hou MC, Wu SL, Chan CC, Huang HC, Lee SD.
    Hepatogastroenterology; 2009 Sep; 56(94-95):1261-7. PubMed ID: 19950773
    [Abstract] [Full Text] [Related]

  • 6. [Role of nitric oxide in alterations of the systemic and splanchnic hemodynamics in a experimental model of portal hypertension].
    Albornoz L, Bandi JC, Sánchez S, Spinedi E, Canteros G, De Paula JA, Galdame O, Mastai R.
    Medicina (B Aires); 1994 Sep; 54(1):17-24. PubMed ID: 7990681
    [Abstract] [Full Text] [Related]

  • 7. Effects of F-180, a new selective vasoconstrictor peptide, compared with terlipressin and vasopressin on systemic and splanchnic hemodynamics in a rat model of portal hypertension.
    Bernadich C, Bandi JC, Melin P, Bosch J.
    Hepatology; 1998 Feb; 27(2):351-6. PubMed ID: 9462630
    [Abstract] [Full Text] [Related]

  • 8. Systemic and splanchnic haemodynamic effects of sildenafil in an in vivo animal model of cirrhosis support for a risk in cirrhotic patients.
    Colle I, De Vriese AS, Van Vlierberghe H, Lameire NH, DeVos M.
    Liver Int; 2004 Feb; 24(1):63-8. PubMed ID: 15102002
    [Abstract] [Full Text] [Related]

  • 9. Serotonin blockade in conscious, unrestrained cirrhotic dogs with portal hypertension.
    Mastaï R, Rocheleau B, Huet PM.
    Hepatology; 1989 Feb; 9(2):265-8. PubMed ID: 2492251
    [Abstract] [Full Text] [Related]

  • 10. Role of prostacyclin in hemodynamic alterations in conscious rats with extrahepatic or intrahepatic portal hypertension.
    Oberti F, Sogni P, Cailmail S, Moreau R, Pipy B, Lebrec D.
    Hepatology; 1993 Sep; 18(3):621-7. PubMed ID: 8359803
    [Abstract] [Full Text] [Related]

  • 11. Hemodynamic changes after ligation of a major branch of the portal vein in rats: comparison with rats with portal vein constriction.
    Um SH, Nishida O, Tokubayashi M, Kimura F, Takimoto Y, Yoshioka H, Inque R, Kita T.
    Hepatology; 1994 Jan; 19(1):202-9. PubMed ID: 8276356
    [Abstract] [Full Text] [Related]

  • 12. [Evaluation of the hemodynamic effects of tumor necrosis factor alpha factor in rats with portal hypertension using the radioactive microsphere technique].
    Pérez-Páramo M, Muñoz J, Albillos A, Rossi I, Alvarez-Mon M, Ortiz Berrocal J.
    Rev Esp Med Nucl; 1998 Jan; 17(4):294-301. PubMed ID: 9721346
    [Abstract] [Full Text] [Related]

  • 13. Splanchnic hyposensitivity to glypressin in a haemorrhage/transfused rat model of portal hypertension: role of nitric oxide and bradykinin.
    Chu CJ, Wu SL, Lee FY, Wang SS, Chang FY, Lin HC, Chan CC, Lee SD.
    Clin Sci (Lond); 2000 Dec; 99(6):475-82. PubMed ID: 11099389
    [Abstract] [Full Text] [Related]

  • 14. Increased blood flow through the portal system in cirrhotic rats.
    Vorobioff J, Bredfeldt JE, Groszmann RJ.
    Gastroenterology; 1984 Nov; 87(5):1120-6. PubMed ID: 6479534
    [Abstract] [Full Text] [Related]

  • 15. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.
    Schroth M, Plank C, Meissner U, Eberle KP, Weyand M, Cesnjevar R, Dötsch J, Rascher W.
    Pediatrics; 2006 Jul; 118(1):e76-84. PubMed ID: 16751617
    [Abstract] [Full Text] [Related]

  • 16. Hyperdynamic circulation in a chronic murine schistosomiasis model of portal hypertension.
    Sarin SK, Mosca P, Sabbà C, Groszmann RJ.
    Hepatology; 1991 Mar; 13(3):581-4. PubMed ID: 1900255
    [Abstract] [Full Text] [Related]

  • 17. Effects of somatostatin on splanchnic hemodynamics and plasma glucagon in portal hypertensive rats.
    Kravetz D, Bosch J, Arderiu MT, Pizcueta MP, Casamitjana R, Rivera F, Rodés J.
    Am J Physiol; 1988 Mar; 254(3 Pt 1):G322-8. PubMed ID: 2894777
    [Abstract] [Full Text] [Related]

  • 18. Nebivolol treatment increases splanchnic blood flow and portal pressure in cirrhotic rats via modulation of nitric oxide signalling.
    Reiberger T, Payer BA, Schwabl P, Hayden H, Horvatits T, Jäger B, Hummel T, Mitterhauser M, Trauner M, Fuhrmann V, Angermayr B, Peck-Radosavljevic M, Vienna Hepatic Hemodynamic Lab.
    Liver Int; 2013 Apr; 33(4):561-8. PubMed ID: 23331709
    [Abstract] [Full Text] [Related]

  • 19. Ritanserin decreases portal pressure in conscious and unrestrained cirrhotic rats.
    Mastai R, Giroux L, Semret M, Huet PM.
    Gastroenterology; 1990 Jan; 98(1):141-5. PubMed ID: 2104540
    [Abstract] [Full Text] [Related]

  • 20. Effects of long-term administration of octreotide in portal vein-stenosed rats.
    Lin HC, Yang MC, Hou MC, Li SM, Huang YT, Yu PC, Tsai YT, Lee SD.
    Hepatology; 1996 Mar; 23(3):537-43. PubMed ID: 8617434
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.